COMMUNIQUÉS West-GlobeNewswire

Abiomed annonce un chiffre d'affaires au T1 de l'exercice financier 2018 de 132,5 millions de dollars, en progression de 29 % par rapport à l'année précédente

28/07/2017 - 15:43

La société annonce le remboursement japonais pour les pompes cardiaques Impella® et augmente la fourchette inférieure de ses prévisions relatives au chiffre d'affaires pour l'exercice financier 2018 DANVERS, [...]

iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region

28/07/2017 - 14:00

iTeos Therapeutics Granted EUR 7.5 Million Non-Dilutive Funding by the Walloon Region Funding will support the clinical development of the Company's lead innovative immuno-oncology drug Gosselies, Belgium - July 28, [...]

U.S. Court of Appeals for the Federal Circuit Affirms Merus' Inequitable Conduct Claim Against Regeneron

28/07/2017 - 13:01

UTRECHT, The Netherlands, July 28, 2017 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that [...]

DBV Technologies Résultats financiers du premier semestre 2017

28/07/2017 - 07:30

Communiqué de Presse Montrouge, France, le 28 juillet 2017 (7H30 CEST) DBV Technologies Résultats financiers du premier semestre 2017 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), société [...]

DBV Technologies Reports First Half 2017 Financial Results

28/07/2017 - 07:30

Press Release Montrouge, France, July 28, 2017 DBV Technologies Reports First Half 2017 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today reported first half 2017 [...]

ACT-541468 (DORA) meets primary endpoint in Phase 2 program in adult and elderly patients with insomnia

28/07/2017 - 07:00

Press release PDF This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]

Navamedic ASA: Second quarter results 2017

28/07/2017 - 07:00

Oslo, 28 July 2017 - Navamedic ASA (OSE: NAVA), reported revenues of NOK 89.7 million in the second quarter of 2017 (NOK 66.7 million in Q2 2016), representing a growth of 34.4%, following the successful ramp-up of the [...]

Essilor - Communiqué : Une performance résiliente au premier semestre

28/07/2017 - 06:30

Une performance résiliente au premier semestre Version PDF du communiqué Hausse de 9,1 % du chiffre d'affaires, dont 6,9 % hors change Meilleure dynamique en Amérique du Nord, bonne performance de l'Europe Pays à forte [...]

Essilor - News Release: Resilient First Half

28/07/2017 - 06:30

Resilient First Half PDF Version of the news release Revenue growth of 9.1% and 6.9% in constant currency Improving momentum in North America, good performance in Europe Fast-Growing Markets impacted by a decline in [...]

Essilor : Mise à disposition du rapport financier semestriel 2017

28/07/2017 - 06:30

Mise à disposition du rapport financier semestriel 2017 Charenton-le-Pont, France (le 28 juillet 2017 - 6h30) - Essilor International publie ce matin son rapport financier semestriel 2017. Ce document comprend les [...]

Essilor: Publication of the 2017 Interim Financial Report

28/07/2017 - 06:30

Publication of the 2017 Interim Financial Report Charenton-le-Pont, France (July 28, 2017 - 6:30 am) - The Essilor International 2017 Interim Financial Report is being published today. The report comprises the interim [...]

Solid financials support R&D progress

27/07/2017 - 22:01

Solid financials support R&D progress This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Servier licenses GLPG1972 in osteoarthritis from Galapagos

27/07/2017 - 22:00

Servier licenses GLPG1972 in osteoarthritis This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are [...]

Novo Nordisk A/S: Victoza® has been approved in the EU as the only GLP-1 with a label to include prevention of cardiovascular events

27/07/2017 - 18:32

Bagsværd, Denmark, 27 July 2017 - The European Commission has approved an update to the Victoza ® (liraglutide) EU label that expands the indication to reflect both improving blood sugar and cardiovascular (CV) events [...]

GUERBET : Chiffre d'affaires au 30 juin 2017

27/07/2017 - 18:03

397,7 M€ à taux de change constant : +5,6% Progression satisfaisante de l'activité Villepinte, le 27 juillet 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie [...]

GUERBET : Revenue at June 30, 2017

27/07/2017 - 18:03

€397.7 million at constant exchange rates, up 5.6% Satisfactory activity growth Villepinte, July 27, 2017 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is [...]

Diaxonhit : Chiffre d'Affaires du 1er semestre 2017 en croissance de 31% à 19,6 millions d'euros

27/07/2017 - 17:57

DIAXONHIT : chiffre d'affaires du 1er semestre 2017 en croissance de 31% Chiffre d'affaires semestriel consolidé en forte progression de +31% à 19,6 millions d'euros, en raison de l'acquisition d'Eurobio le 30 mars 2017 [...]

Oriola Corporation - Repurchase of own shares on 27 July 2017

27/07/2017 - 17:45

ORIOLA CORPORATION STOCK EXCHANGE RELEASE 27 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 27 July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 11 209 Average price/share, EUR 3,5995 Total [...]

Ossur Hf : Insider Trading

27/07/2017 - 16:50

Announcement Össur hf. No.53/2017 Reykjavík, 27 July 2017 Auðkenni útgefanda/Trade ticker: OSSR Nafn útgefanda/Issuer: Össur hf. Dagsetning tilkynningar/Date of announcement: 27 July 2017 Nafn fruminnherja/Name primary [...]